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Abstract   
 
There is increasing evidence to suggest both a symptomatic overlap and a clinically significant 
degree of co-occurrence between Autism Spectrum Disorders (ASD) and psychotic disorders 
such as schizophrenia but the nature of such relationships remain unclear. We reviewed the 
literature reporting prevalence rates of Autistic-like Traits (ALTs) and ASD in populations with 
a diagnosis of schizophrenia or other psychotic disorder. A search of three large databases was 
conducted and from this seven studies met the criteria for inclusion. The point prevalence rates 
for ALTs ranged from 9.6% to 61%, whilst the prevalence rates for diagnosed ASD ranged from 
<1% to 52% across outpatient and inpatient populations. This suggests that prevalence rates of 
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ALTs and ASD in psychosis populations are much higher than in the general population. This 
has important implications regarding future research, and clinical implications in terms of 
ensuring that patients receive the most appropriate diagnosis and treatment.   
Keywords 
Schizophrenia, Autism, Asperger’s, Co-morbid, co-occur.   
 
1. Introduction  
In recent years there has been increasing interest in the relationship between psychotic 
symptoms, psychotic disorders (such as schizophrenia), and symptoms consistent with Autism 
Spectrum Disorders (ASD). Historically there was much confusion in this field. A century ago, 
Bleuler considered “autism” to be one of the four core symptoms of schizophrenia (Askok et al., 
2012). In the middle part of the twentieth century, the terms schizophrenia and autism were often 
used synonymously in childhood. It was not until the 1970’s that Kolvin (1971) and Rutter 
(1972) clearly defined ASD and childhood schizophrenia as separate disorders (Chisholm et al., 
2015). They remain classified as separate constructs within current diagnostic classification 
systems.  
 
ASD is a childhood-onset developmental disorder and its diagnosis is dependent upon evidence 
of impairments in social communication and social interactions, in addition to persistent 
restricted, repetitive patterns of behaviour or interests. Publication of the fifth edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) has seen previously distinct 
subtypes of ASD such as Asperger’s Syndrome (AS) subsumed within the category of ASD, 
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under neuro-developmental disorders. The prevalence of ASD is estimated to be approximately 
one percent of the population (Brugha et al., 2011) and it is well documented that individuals 
with a diagnosis of ASD are predisposed to a variety of other mental health difficulties and co-
morbidities.  
 
 
The population prevalence of schizophrenia is estimated to be one percent (Bradley et al., 2011) 
and ASD may present a risk factor for the development of schizophrenia (Nylander et al., 2008). 
DSM-5 and International Classification of Diseases (ICD-10) criteria for schizophrenia relate to 
the presence of two of more of the following symptoms: hallucinations, delusions, disorganised 
speech, disorganised (or catatonic) behaviour, and negative symptoms, present for a significant 
duration throughout a one month period. Where there is childhood onset of ASD or another 
communication disorder, a DSM-5 diagnosis of schizophrenia will only be made if there is 
evidence of prominent hallucinations or delusions for at least one month.  
 
ASD and schizophrenia are both characterised by atypical neurodevelopment of language and 
difficulties with social interaction and communication; however, individuals diagnosed with 
Asperger’s Syndrome (AS) as per the DSM-IV classification system by definition do not have 
significant delay in language or cognitive development (Davidson et al., 2014: Raja & Azonni, 
2001; Solomon et al., 2011). The impairments in social functioning common to both 
presentations may be underpinned by overlapping psychological mechanisms such as Theory of 
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Mind (ToM) impairments, which though a feature of both disorders, are not identified in current 
diagnostic criteria (Chisholm et al., 2015).  
 
ASD symptoms appear to overlap most significantly with negative symptoms of schizophrenia. 
For example, difficulties with emotional reciprocity, or speech delay or absence observed in 
ASD may be understood in terms of blunting of affect or alogia (poverty of speech) in 
schizophrenia, respectively. Catatonic features may also present in both disorders. Phenotypic 
similarities can therefore result in difficulties with differential diagnosis according to 
classification systems such as the DSM which are based upon observation of specified clinical 
symptoms. Conversely, positive symptoms such as hallucinations and delusions are defining 
features of schizophrenia but are not typically symptomatic of ASD. Age of onset constitutes 
another significant distinction between the two constructs (Konstantareas & Hewitt, 2001).  
 
Whilst there is some evidence to suggest that ASD and schizophrenia co-occur at elevated rates, 
there is a lack of systematic research on the co-occurrence of these two disorders (Chisholm et 
al., 2015; Davidson et al., 2014; del Real et al., 2010). A systematic review attempting to 
ascertain the prevalence rates of psychosis, anxiety and affective disorders in ASD populations 
reported prevalence rates of schizophrenia between 0% and 6%. Comparison across studies was 
complicated by substantial methodological heterogeneity and some of the included studies 
reported on prevalence rates in child and adolescent populations and therefore may have 
underestimated the prevalence of symptoms yet to emerge (Skokauskas & Gallagher, 2010). A 
similar systematic review reported difficulties in drawing accurate conclusions about the co-
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occurrence of psychosis and Pervasive Developmental Disorders (PDD) due to methodological 
variation, heterogeneity and issues of selection bias. The authors highlighted the importance of 
future research in order to understand the potential mechanisms underpinning their co-morbidity 
(Padgett et al., 2010). There is no published research known to the authors which systematically 
reviews the prevalence of ASD in adult psychosis populations. It should be acknowledged 
however, that there have been a number of studies which have explored the relationship between 
childhood-onset schizophrenia and ASD. A longitudinal study carried out by the National 
Institute of Mental Health (NIMH) in 2004 found that 25% of 75 children with a diagnosis of 
childhood-onset schizophrenia had a lifetime diagnosis of ASD: one met criteria for autism, two 
for AS, and 16 for Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) 
(Sporn et al., 2004). This result was replicated with a larger sample size of 101, showing a 
similar proportion (28%) with a lifetime diagnosis of ASD (Rapoport et al., 2009). A study 
carried out by Hallerbäck and colleagues (2012) in a Swedish population of patients with a 
Schizophreniform illness found that 41% met diagnostic criteria for ASD based upon interviews 
carried out with their parents, with particular focus on the presence of ASD symptomatology in 
childhood and adolescence. 
 
The present review therefore aims to assimilate all published studies reporting such prevalence 
rates.  The literature pertaining to both psychosis and ASD is primarily diagnostically based at 
present therefore this review will explore prevalence rates in accordance with the relevant 
diagnostic categories. Furthermore, as both disorders are proposed to exist on a continuum of 
severity, it is important to consider not only the prevalence of diagnosed ASD, but also “sub-
threshold” ASD symptoms or traits referred to hereafter as Autistic-like Traits (ALTs). ALTs 
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include symptoms consistent with the diagnostic symptom profile for ASD as measured by 
quantitative ASD symptom scales or concurrence with diagnostic criteria. Importantly, ALTs 
refer to the presence of ASD symptoms at the time of assessment but may lack evidence or 
assessment of their presence in childhood, which is essential for a diagnosis of ASD. It is these 
(often overlapping) traits which form the essential criteria for diagnosis therefore this review 
may represent a first step in untangling a complex relationship between two overlapping 
constructs. Understanding the prevalence rate of ALTs and ASD in psychosis populations is an 
important step towards further understanding the overlaps and distinctions between the 
constructs, which has significant implications for both psychological and pharmacological 
interventions, in addition to diagnosis and policy (Chisholm et al., 2015; Mandell et al., 2012).   
 
2. Methods 
Studies were identified through searches of three large electronic databases: PsychINFO, Web of 
Science and PubMed. No date restrictions were imposed and the search strategy included the 
following groups of keywords: (a) schizo*, psychos*, psychot* OR delusion*; (b) ASD, 
asperger* OR autis*; (c) prevalence OR co-morbid*. These groups were then combined using 
the Boolean operator AND. The systematic literature search was conducted independently by 
two reviewers on the 4
th
 December 2015.  
 
Studies were considered eligible for inclusion if they fulfilled the following criteria: included 
participants with a psychotic disorder and details of how this was assessed or classified; provided 
details on assessment of ASD (or ALTs) and outcomes; prevalence rates of ASD (or ALTs) 
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specified (or discernable from the available information); and published in English, in a peer-
reviewed journal. Studies were excluded if all participants were from either an ASD population 
or an Intellectual Disability (ID) population as ASD is known to co-occur at a higher rate with 
ID (Brugha et al., 2011).   
 
Studies were reviewed in accordance with the PRISMA Statement (Moher et al., 2009). Studies 
were identified for inclusion and reference lists of included studies were reviewed independently 
by two reviewers (DK & MD). Both reviewers assessed the quality of articles included in the 
review and extracted pertinent data including study design and setting, sample demographics, 
details of psychosis and ASD variables, prevalence rates, and conclusions. Any disagreement 
was resolved through discussion or by contacting authors for additional details. A narrative 
synthesis of studies was undertaken due to the variability in the measurement of variables.   
3. Results  
The database search identified 1388 records and of these, 324 were removed due to duplication. 
The remaining 1064 records were screened by title and abstract. Sixteen potential studies for 
inclusion were subsequently identified therefore full text articles were sought and eligibility was 
assessed. Of these, seven studies met the criteria and were included in the review. Review of the 
reference lists did not yield any additional relevant studies. Figure 1 provides an overview of the 
review process.  
8 
 
 
Figure 1. Flowchart detailing the systematic review process 
Of the nine excluded full-text articles, two studies had duplicate samples (therefore the most 
recent publication was included in the review) and one study included participants who did not 
clearly fit a schizophrenia diagnosis. The prevalence rate was not specified or discernable for 
three studies (and details were not obtainable despite contacting authors). The findings of two 
studies related to an ID sample, whilst another study reported prevalence of co-morbidity in an 
ASD population. The level of agreement between reviewers was high, as evidenced by a 
weighted Kappa rating of 0.90. Table 1 provides a summary of the studies included in the 
review.  
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Table 1: Study Characteristics 
Authors  Setting & 
Location  
Psychosis  
Sample 
Size [& 
Total 
Sample 
Size] 
Age 
Range 
of 
Total 
Sample 
(Years) 
Gender 
of total 
study 
(%) 
Psychosis Diagnosis 
& Classification  
ASD Variable 
& 
Classification  
ID (IQ 
<70 in 
Total 
Sample) 
(%) 
Matsuo et 
al. (2015) 
Hospital/ 
Clinic 
Outpatients, 
Japan   
44 
[290] 
25-59  46  
Male   
54 
Female  
Schizophrenia  
DSM-IV-TR 
ALTs 
SRS-A 
0 
Davidson 
et al. 
(2014)  
Early 
Intervention in 
Psychosis 
Service, 
England 
(Predominantly 
outpatients) 
197 14-35 57 
Male 
43 
Female  
Psychotic Disorder  
ICD-10 
AS 
DSM-IV & 
ASDASQ 
0 
Waris et 
al. (2013)  
Psychiatric 
Rehabilitation 
Unit Inpatients, 
Finland  
18 13-17 39 
Male 
61 
Female  
Schizophrenia  
DSM-IV 
AS 
DISCO 11 
0 
Mandell et 
al. (2012)  
Psychiatric 
Hospital 
Inpatients, 
USA 
123  
[141] 
26-82 68.8 
Male  
31.2 
Female  
Schizophrenia  
SAPS & SANS 
ASD 
ADI-R & SRS 
32.6% 
Hallerback 
et al. 
(2012)  
Psychiatric 
Clinic 
Outpatients, 
Sweden  
42 
[46] 
- 
(Mean 
28.3 
SD 4.7) 
63 
Male  
37 
Female  
Schizophrenia, 
Schizophreniform 
Disorder or 
Schizoaffective 
Disorder  
DSM-IV 
ASD 
DISCO 11 & 
AQ  
0 
Fraser et 
al. (2012) 
Youth Mental 
Health Service 
Outpatients, 
Australia  
292 
[476] 
15-25  N/A Psychotic Disorder  
DSM-IV 
AS, Autistic 
Disorder & 
ALTs 
DSM-IV 
-  
Chang et 
al. (2003) 
Psychiatric 
Clinic 
Outpatients, 
Taiwan  
128 
[660] 
15-93  57 
Male  
43  
Female  
Schizophrenia  
DSM-IV 
ASD 
DSM-IV & 
ASDASQ  
≥0.76% 
* 
ASD: Autism Spectrum Disorder; ID: Intellectual Disability; DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 
Fourth Edition, Text Revision; ALTs: Autistic-like Traits; SRS-A: Social Responsiveness Scale for Adults; ICD-10: International 
Classification of Diseases Version 10; AS: Asperger’s Syndrome; ASDASQ: Autism Spectrum Disorder in Adults Screening 
Questionnaire; DISCO-11: Diagnostic Interview for Social and Communication Disorders Version 11; SAPS: Scale for the 
Assessment of Positive Symptoms; SANS: Scale for the Assessment of Negative Symptoms; ADI-R: Autism Diagnostic 
Interview- Revised; AQ: Autism Quotient.  
*Exact details not provided however this figure should be regarded as the minimum % of participants with an ID.
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Each of the seven studies included in the review were conducted in a different country, spanning 
the continents of Europe, North America, Australia and Asia. All studies were of a cross-
sectional design, and included participants who had a confirmed diagnosis of schizophrenia or 
other psychotic disorder.  Each study assessed ASD symptoms however there was variability 
among studies in terms of how this was assessed. Four studies used both screening and 
diagnostic assessments of ASD (Davidson et al., 2014, Mandell et al., 2013, Hallerback et al., 
2012 and Chang et al., 2003), whilst Waris and colleagues (2013) utilised diagnostic interview 
only. Matsuo et al. (2015) employed a screening measure only, whereas Fraser et al. (2012) 
reported on existing ASD diagnoses previously confirmed by appropriate healthcare 
professionals, in addition to clinician opinion according to DSM-IV criteria. Study samples were 
primarily from outpatient populations with the exception of Waris et al. (2013) and Mandell et 
al. (2012) who reported on inpatients (See Table 1 for additional details).  
 
The sample demographics (age range and gender) presented in Table 1 relate to the total sample 
included in each study, rather than the psychosis sample utilised by this review. Similarly, the ID 
data presented in Table 1 relates to the total psychiatric sample and not specifically the psychosis 
sample. Mandell et al. (2012) and Chang et al. (2003) were the only studies who included 
participants with an ID (as defined by an IQ score of less than 70). ID was an exclusion criterion 
for most other studies however data relating to IQ was not collected by Fraser et al. (2012).  
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Table 2: Overview of results  
Authors Quality 
Score 
Prior ASD 
Diagnosis and 
classification 
Prevalence of 
ALTs 
 
Prevalence of 
Diagnosed ASD 
Matsuo et al. 
(2015) 
16/18 0% 61% - 
Davidson et al. 
(2014) 
17/18 1.5% AS 
0.5% HFA 
10.7% 3.6% AS 
Waris et al. 
(2013) 
15/18 5.5% PDD 56% 11.1%  AS; 
5.6% PDD-NOS 
Mandell et al. 
(2013) 
16/18 0% - 9.8% ASD 
Hallerback et al. 
(2012) 
16/18 - - 52% ASD 
Fraser et al. 
(2012) 
14/18 3.4% ASD 9.6% 3.4% ASD 
Chang et al. 
(2003) 
13/18 0.8% ASD 18.8% 0.78% ASD 
AS: Asperger’s Syndrome; HFA: High-functioning Autism; PDD: Pervasive Developmental Disorder; PDD-NOS: 
Pervasive Developmental Disorder Not Otherwise Specified; ASD: Autism Spectrum Disorder.  
 
 
The prevalence rates of diagnosed ASDs were reported for all studies with the exception of 
Matsuo et al. (2015). These rates ranged from 0.78% to 52%, and related predominately to ASD 
but also included AS and PDD-NOS subcategories. Details of the prevalence of ALTs or ASD 
symptoms which did not meet the criteria for diagnosis were available from most of the studies 
except Mandell et al. (2013) and Hallerback et al. (2012). Again, there was considerable 
variation in the observed rates which ranged from 9.6% to 61%.  
 
Four studies provided details on existing diagnoses of ASD prior to inclusion in their study 
(Davidson et al., 2014, Waris et al., 2013, Fraser et al., 2012 and Chang et al., 2003) and in two 
cases the number of individuals who received a diagnosis of ASD increased (Davidson et al., 
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2014; Waris et al., 2013).  Matsuo et al. (2015) excluded individuals with an existing diagnosis 
of ASD, and whilst Mandell et al. (2013) did not impose this as an exclusion criterion, nearly a 
tenth of their participants received a diagnosis of ASD despite no pre-existing diagnoses. 
Hallerback et al. (2012) did not report on this despite the researcher attempting to make contact 
with the author. See table 2 for further information. Interestingly, Hallerback et al. (2012) was 
the only study to investigate potential relationships between subtypes of ASD and subtypes of 
schizophrenia. Their results demonstrated the highest rate of ASD (60%) co-occurring within the 
‘paranoid schizophrenia’ subgroup.   
 
Quality assessment  
The quality of studies was assessed through discussion by both reviewers in accordance with the 
assessment criteria delineated by Kmet et al. (2004). Criteria 5-7 were omitted as these related to 
interventional studies, as were criteria 11-12 as these referred to analyses not relevant to 
prevalence studies. Table 2 provides details of the quality assessment scores, alongside 
prevalence rates of ALTs and ASD reported by each study. The studies included in the review 
were considered to be of fair-to-high quality. There was a clear rationale provided for each study, 
and each author’s conclusions were supported by their outcomes. All-but-two studies used 
reliable and valid diagnostic criteria and subsequent interview instruments to confirm a diagnosis 
of schizophrenia or other psychotic disorder: Fraser et al. (2012) used DSM-IV criteria however 
did not employ a diagnostic interview, whilst Chang et al. (2003) also used DSM-IV criteria for 
schizophrenia however did not provide details of how this was assessed.  
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There was a high degree of methodological variation in the measurement of ASD symptoms; 
however, the highest-rated studies tended to be those who employed both screening and 
diagnostic assessments of ASD (Davidson et al., 2014, Mandell et al., 2012, Hallerback et al., 
2012). Three quantitative measures of ASD symptoms were used across five studies. The Social 
Responsiveness Scale for Adults (SRS-A) was used by Mandell et al. (2012) and Matsuo et al. 
(2015). It has sufficient sensitivity and specificity for adult populations however there is a lack of 
data on reliability in a psychosis population. Mandell et al. (2012) did not report sufficient details 
to enable calculation of the prevalence of ALTs in their sample as they claimed that it did not 
have sufficient specificity (for assessing ASD at the diagnostic level) in their sample of 
predominantly long-stay in-patients with complex needs. The Autism Spectrum Disorder in 
Adults Screening Questionnaire (ASDASQ) was used for screening by Chang et al. (2003) and 
Davidson et al. (2014), the latter of whom suggested that the Gillberg criteria on which it is 
based may be superior to the DSM-IV or ICD-10 criteria. The authors of this measure report 
good psychometric properties including high levels of internal consistency, fair-to-moderate test-
retest reliability and inter-rater reliability, in addition to high specificity and sensitivity 
(Nylander & Gillberg, 2001). The aforementioned measures were all completed by individuals 
known to the patient such as family or healthcare professionals. Hallerback et al. (2012) was the 
only study to use a self-report measure, namely the Autism Quotient (AQ), as a screening tool 
for autistic traits but did not report on the outcomes of this therefore the prevalence of ALTs 
were not discernable from this study. 
Three ASD diagnostic instruments were employed throughout five studies: Mandell et al., (2012) 
used the Autism Diagnostic Interview- Revised (ADI-R) which they identified as the ‘gold 
standard’ diagnostic interview schedule for ASD although there is a paucity of research 
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concerning its reliability for use with this population. The Diagnostic Interview for Social and 
Communication Disorders Version 11 (DISCO-11) is considered to have high agreement with 
ADI-R classification, in addition to excellent psychometric properties however schizophrenia is 
an exclusion criterion in the diagnostic algorithm (Waris et al., 2013). Waris et al. (2013) used 
this instrument in their sample of adolescents with schizophrenia, yet they did not make 
reference to any adaptations to the tool and reported on diagnostic prevalence despite the caveat 
for diagnosis. Prevalence of ALTs was also discernable from these assessments: more than half 
of participants fulfilled the diagnostic symptom profile for AS at the time of assessment, in 
contrast to the number of individuals who received a genuine diagnosis of AS based on evidence 
of its origins in childhood (11.1%). Of interest, all participants were found to exhibit at least one 
of the principal symptoms of PDD in adolescence. The DISCO-11 was also used by Hallerback 
et al. (2012) but was adapted to omit questions pertaining to schizophrenia and this may have 
implications for the validity and comparability of their findings.  
 
Diagnostic interviews based on DSM-IV diagnostic criteria were utilised by both Davidson et al. 
(2014) and Chang et al. (2003) however neither author identifies the specific diagnostic 
interview (e.g. SCID). The separate categorization of ASD and schizophrenia in the DSM-IV 
presents a similar obstacle in that there appears to be an “either-or” position regarding diagnosis 
of the two constructs however neither study delineates how they managed this complexity. Of 
note, Fraser et al. (2012) also employed DSM-IV criteria as a screening assessment using 
clinician judgment (rather than diagnostic interview) in order to identify potential ALTs. This 
was accompanied by professional training sessions which aimed to enhance clinician awareness, 
knowledge and understanding of ASD and co-morbidities; however, these sessions were not 
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mandatory and the inter-rater reliability of the screening process was not formally assessed. 
Furthermore, they identified individuals with an existing diagnosis of ASD, which was 
previously assessed using the ADI, and potentially an additional ADOS assessment.  
 
Sample size negatively impacted on the quality ratings of four studies. Both Matsuo et al. (2105) 
and Hallerback et al. (2012) had relatively small sample sizes when considering outpatient 
populations with psychosis as less than 100 participants may not be a truly representative sample 
(Chisholm et al., 2015). Whilst Waris and colleagues’ (2013) sample size is considered small in 
terms of a prevalence study (N= 18), it did include all the patients of rehabilitations units for 
adolescents with schizophrenia within a Hospital District in Finland. The sample size in Mandell 
et al.’s (2012) inpatient study was acceptable (N= 123) however this represents less than half of 
the eligible individuals.  
 
4. Discussion  
Overall, the findings of this review demonstrate elevated prevalence rates of ASD at the 
diagnostic level and at the trait level in psychotic populations compared to the general 
population. The co-occurrence of psychosis and ALTs is evidently more frequent than ASD at 
the diagnostic level. The wide-ranging prevalence rates highlighted by this review are 
problematic in terms of estimating the actual prevalence rates, and may be in part attributable to 
the variability in measurement and methodology used across the studies. These findings provide 
evidence of symptomalogical overlap between the two disorders; however, the wide-ranging 
prevalence rates may reflect issues regarding the conceptualization of symptoms within current 
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diagnostic classification systems. Both schizophrenia and ASD are considered to be chronic, 
multi-factorial disorders which include clinical presentations across a continuum of severity and 
disability. Issues pertaining to high heterogeneity within both constructs are therefore 
problematic for psychiatric classification systems which rely on the presence of specified clinical 
symptoms (Solomon et al., 2008). In addition to shared symptomatolgy and risk factors, genetic 
studies have highlighted direct and indirect links between ASD and schizophrenia (Hallerback et 
al., 2012). Phenotypic similarities between these two presentations illustrate an inherent problem 
regarding diagnosis, and can result in difficulties with differential diagnosis. Furthermore, 
exclusion criteria outlined in diagnostic categories may preclude the diagnosis of both disorders 
simultaneously.  
 
As ASD is a developmental disorder which by definition is present from early childhood, it is 
essential to consider an individual’s development history in order to discriminate between true 
ASD and ALTs which may currently map onto diagnostic criteria. Four of the six studies 
reporting on ASD diagnosis utilised developmental history to inform diagnosis via interviews 
with parents or family members known to the participant during childhood (Waris et al. 2013 ; 
Mandell et al. 2012; Hallerback et al. 2012; Fraser et al. 2012); however, both Davidson et al. 
(2014) and Chang et al. (2003) sought historical information from family members where 
possible. Reliance on retrospective information from family members has advantages in that they 
are likely to have the best knowledge of their child however it also has drawbacks which include 
the potential influence of recall bias. Childhood development is of further interest when 
considering the evidence suggesting that schizophrenia spectrum disorders may be more 
prevalent in children who meet the criteria for both PDD-NOS and Multiple Complex 
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Developmental Disorder (MCDD) compared to Autistic Disorder (‘classic autism’). Whilst the 
construct of MCDD is not currently recognized within psychiatric classification systems, it 
appears to offer a way of conceptualizing the subset of children whose complex 
neurodevelopmental symptom patterns traverse diagnostic boundaries between ASD and 
psychosis by exhibiting social functioning impairments and reality testing impairments (Cochran 
et al., 2013).  
 
With the exception of Waris et al. (2013), the assessment of ALTs was of a cross-sectional 
nature whereby the current or recent presence of a symptom (e.g. within the past 6 months) was 
recorded although childhood presence was not explored. Nevertheless, their purpose was 
primarily to highlight individuals exhibiting symptoms consistent with ASD to allow for further 
assessment and possible diagnosis. All of the aforementioned ALT screening methods were 
observer-rated assessments which were informed by either a family member or a clinician known 
to the participant. Whilst observational tools are recognized as a valid way of screening for 
symptoms which are indicative of ASD, it is well documented that they are not capable of 
differentiating between negative symptoms of schizophrenia and ASD traits (Hallerback et al., 
2012). The prevalence rate of diagnosed ASD reported by Fraser et al. (2012) related to 
diagnoses made by a pediatrician, psychiatrist or clinical psychologist prior to inclusion in the 
study. Despite concerns regarding the validity of observational assessments, their sample was 
from a youth mental health service therefore it is possible that a diagnosis of ASD was 
established prior to psychosis onset and would therefore be valid.  
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Research attempting to understand the mechanisms underpinning the symptomalogical overlap 
between ASD and psychosis have identified substantive similarities and differences in several 
dimensions relevant to both disorders including cognitive dysfunction (memory, language and 
non-verbal reasoning), social functioning (including ToM), genetics and brain abnormalities. 
These phenotypic and genotypic similarities and vulnerabilities are suggestive of commonalities 
between the two constructs and therefore it appears plausible that some of these features may be 
responsible for the overlapping symptoms observed in both disorders for example ToM 
impairments underpinning social difficulties. It may therefore be conceived that the differences 
within the aforementioned dimensions may in part represent an interaction between aetiological 
and environmental components. It has been proposed that these overlaps may actually represent a 
more expansive set of overlaps across all neurodevelopmental disorders (Stone & Iguchi, 2011).  
 
Directionality may constitute another important factor in the association between the two 
disorders. It is well established that the development of psychotic illness is associated with 
aversive childhood and adulthood experiences such as bullying and trauma (Cunningham et al., 
2015). Individuals with disorders such as ASD may be at an increased risk of victimization 
perhaps as a result of social and communication difficulties. Given that ASD has been identified 
as a risk factor for the development of psychosis (Van Roekel et al., 2010), it therefore seems 
possible that ASD symptoms such as impairments in social functioning may increase experiences 
of bullying, which in turn increases the risk of developing psychosis.  
 
4.1 Conclusions   
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Overall, the results appear to consistently demonstrate that there is a higher prevalence of ALTs 
and ASD in psychosis populations compared to the general population in spite of methodological 
variance. Furthermore, the methodological shortcomings of studies imply an under-
representation of ASD and ALTs prevalence within this population. Two studies are exceptions 
to this: Fraser et al. (2012) claim that their results may over-estimate the prevalence of ASD 
however do not explicitly clarify this viewpoint, whilst Hallerback et al. (2012) acknowledge the 
potential influence of gender in their predominantly male sample, given that ASDs are 
approximately four times more prevalent in males (Werling & Geschwind, 2013) . Even so, it 
seems reasonable to conclude that ASD and ALTs are under-identified within this population, 
and therefore these outcomes are likely to serve as a minimum prevalence rate. The relationship 
between the two disorders appears to be maintained regardless of ASD diagnostic status.  
 
The review highlighted a large difference between ASD prevalence rates prior to inclusion in 
studies and post-assessment, which parallels the findings of other studies in that the observed 
level of ASD was significantly higher than the number of people who carried that diagnosis prior 
to inclusion (Nylander & Gillberg, 2001; Scragg & Shah, 1994). This apparent discrepancy is 
somewhat more concerning when it is considered that participants across all studies were in 
contact with mental health services. Chang et al. (2003) is an exception to this as participants 
were first-visit attenders to their service. Davidson et al. (2014) suggests that there are a 
significant number of adults living with undiagnosed ASD within the UK. ASD is increasingly 
being assessed and diagnosed in adults and older adults although further research is necessary in 
order to develop appropriate instruments to assess these adult populations (Hallerbacket al., 
2012; Mandell et al., 2015). Whilst more profound ASD difficulties are generally associated with 
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an earlier age of diagnosis, higher-functioning individuals may not be so readily identified during 
childhood and therefore ASD may have remained undiagnosed until adolescence or adulthood 
following contact with mental health services (Fraser et al., 2012).  
 
Some of the study samples were very specific (for example adolescent inpatients) and some of 
the measures lacked data on their reliability or validity for use with a psychosis population, 
therefore caution is warranted in the interpretation and generalization of results. Also, none of 
the studies utilized the most current diagnostic criteria; the DSM-5. Nevertheless, the core 
diagnostic criteria for schizophrenia have been retained from DSM-IV therefore it is conceivable 
that participants who received a DSM-IV diagnosis of schizophrenia are likely to have continued 
to fulfill the diagnostic criteria. In contrast to the previously separate subtypes of ASD outlined 
in the DSM-IV (as used by the studies in this review), the DSM-5 category of ASD includes the 
entire spectrum of presentations. Classification according to ASD subtypes made comparison 
across studies awkward therefore the term ASD was predominantly throughout this review in 
accordance with the DSM-5 classification. This seems appropriate given that ASD is a 
heterogeneous spectrum disorder and therefore there is natural variation even within the 
diagnostic criteria.  
 
Davidson et al., (2014) posits that the concurrence between AS and psychotic disorders may 
actually represent misdiagnosis of AS rather than true co-morbidity, for example tactile 
hallucinations in schizophrenia may be understood as sensory processing issues in AS. 
Misdiagnosis of AS as psychosis may have significant implications for clients in terms of their 
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treatment, for example the side effects of anti-psychotic medications may include impaired 
motor functioning, which could in turn potentially be considered as symptomatic of PDD. The 
presence of ASD symptoms since early childhood is essential for accurate diagnosis therefore the 
importance of gathering a detailed developmental history and the subsequent difficulties in 
obtaining this information was highlighted by a number of studies. Overlapping symptoms and 
confusion surrounding symptoms clearly presents a difficultly regarding differential diagnosis 
 
This review has highlighted symptomalogical overlaps between these two constructs, which may 
go some way to contesting the current diagnostic conceptualization of these disorders as entirely 
separate conditions. That said, the degree of overlap at the ASD diagnostic level (provided 
diagnosis is informed by developmental history) continues to support a degree of diagnostic 
distinction between the two constructs (Stone & Iguchi, 2011). The findings of this review 
encourage speculation as to shared aetiological and/or psychological mechanisms which may 
underpin the continua of both disorders.  
 
 
4.2 Implications 
This review has highlighted the need for large-scale epidemiological studies in order to establish 
accurate rates of co-occurrence of the two disorders, and revision of diagnostic criteria may be 
required in order to facilitate recognition of their co-occurrence (Davidson et al., 2014; Stahlberg 
et al., 2004). Discrepancy between ASD identification pre-and-post research studies highlights 
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the need for better screening and identification of ALTs in individuals presenting with psychotic 
symptoms, however further research is required in order to enhance understanding of the 
overlapping and distinguishing features of ASD and psychosis in order to facilitate differential 
diagnosis. As diagnosis informs both psychological and pharmacological intervention, the 
gravity of appropriate diagnosis must be appreciated when the severe and debilitating side-
effects of anti-psychotic medication are considered. There is a clear need to better understand the 
relationship between the emergences of ALTs alongside psychotic phenomenon where traits 
have not been present during childhood therefore future research should aim to address this 
issue. Regardless of whether an individual meets the threshold for diagnosis or not, developing a 
better understanding of the complex relationship between these two conditions has significant 
clinical implications in terms of enhanced screening, diagnosis, early intervention and prognosis, 
ultimately in order to improve quality of life for affected individuals (Chisholm et al., 2015).  
 
4.3 Limitations 
This review is subject to certain limitations. Publication bias may mean that only published 
studies were included. One of the exclusion criteria for this review was a study sample from an 
ID population, which may have implications for the generalisability of results as ASD is often 
associated with ID. However, two studies assessed the prevalence of AS and therefore excluded 
participants with ID (as by definition, individuals with AS do not have ID) and two of the 
included studies had a minority of participants with ID, which may therefore improve the 
ecological validity of the findings of this review. Whilst the study explored sub-threshold ASD 
traits (ALTs), it did not take account of the literature pertaining to sub-threshold psychotic 
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presentations such as At Risk Mental State (ARMS) criteria however the focus of the review was 
to ascertain the prevalence rates of ASD and ALTs within a psychosis population, whereas not 
all individuals who present with ARMS will develop a psychotic illness.  
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Supplementary Appendix  
Kmet et al. (2004) Quality Assessment Criteria (criteria 5, 6, 7, 11 & 12 omitted) 
 Criteria  Yes 
(2) 
Partial 
(1) 
No 
(0) 
N/A 
1 Question/ objective sufficiently described?      
2 Study design evident and appropriate?      
3 Method of subject/ comparison group selection or source 
of information/ input variables described and appropriate?  
    
4 Subject (and comparison group, if applicable) 
characteristics sufficiently described?  
    
8 Outcome and (if applicable) exposure measure(s) well 
defined and robust to measurement/ misclassification 
bias? Means of assessment reported?  
    
9 Sample size appropriate?     
10 Analytic methods described/ justified and appropriate?      
13 Results reported in sufficient detail?      
14 Conclusions supported by the results?      
          Total Score:  
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Highlights 
 Rates of ASD and ASD traits are elevated in a psychosis population  
 Despite overlaps, there remains a diagnostic distinction between the two disorders  
 Large-scale epidemiological studies are required to ascertain rates of co-occurrence  
 
